Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies

By Isobe Yasushi   Kanemitsu Naoko   Yahata Yuriko   Masuda Azuchi   Tsukune Yutaka   Sugimoto Koichi  

Scandinavian Journal of Infectious Diseases, Vol. 41, Iss. 3, 2009-01 ,pp. : 237-239

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Cefepime and Ceftazidime in Combination with Amikacin in the Empirical Treatment of High-risk Patients with Febrile Neutropenia: A Prospective, Randomized, Multicenter Study

By Erman Mustafa   Akova Murat   Akan Hamdi   Korten Volkan   Ferhanoğlu Burhan   Köksal Iftihar   Çetinkaya Yeşim   Uzun Ömrüm   Ünal Serhat  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study

By Sanz Miguel A.   Bermúdez Arancha   Rovira Montserrat   Besalduch Juan   Pascual Maria-Jesus   Nocea Gonzalo   Sanz-Rodríguez César    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 645-656

Informa Healthcare

Access to resources Recommend Favorite

Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan

By Koh Hideo   Hino Masayuki   Ohta Kensuke   Iino Masaki   Urase Fumiaki   Yamaguchi Masaki   Yamanouchi Jun   Usui Noriko   Yoshida Minoru   Tanimoto Mitsune   Ohyashiki Kazuma   Urabe Akio   Tamura Kazuo   Kanamaru Akihisa   Masaoka Tohru  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 6, 2013-12 ,pp. : 1126-1134

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Micafungin as an Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-07 ,pp. : 92-97

Karger

Access to resources Recommend Favorite